ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -29.5% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $417 | -12.6% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $477 | -74.5% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,869 | -6.6% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $8,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | -27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | -26.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | +66.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -45.5% | 300 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $22,000 | +10.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $20,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $15,000 | +7.1% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | +175.0% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | +75.0% | 300 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | -50.0% | 150 | +50.0% | 0.00% | 0.0% |
| Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |